America's Opioid Epidemic: Supply and Demand Considerations

被引:77
|
作者
Clark, David J. [1 ]
Schumacher, Mark A. [2 ]
机构
[1] Stanford Univ, Dept Anesthesiol, 3801 Miranda Ave, Palo Alto, CA 94304 USA
[2] UCSF, Div Pain Med, Dept Anesthesia & Perioperat Care, San Francisco, CA USA
来源
ANESTHESIA AND ANALGESIA | 2017年 / 125卷 / 05期
关键词
DRUG-MONITORING PROGRAM; ABUSE-DETERRENT FORMULATIONS; LOCK-IN PROGRAMS; INDUCED HYPERALGESIA; UNITED-STATES; CHRONIC PAIN; EXTENDED-RELEASE; PRESCRIPTION; HEALTH; MANAGEMENT;
D O I
10.1213/ANE.0000000000002388
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
America is in the midst of an opioid epidemic characterized by aggressive prescribing practices, highly prevalent opioid misuse, and rising rates of prescription and illicit opioid overdose-related deaths. Medical and lay public sentiment have become more cautious with respect to prescription opioid use in the past few years, but a comprehensive strategy to reduce our reliance on prescription opioids is lacking. Addressing this epidemic through reductions in unnecessary access to these drugs while implementing measures to reduce demand will be important components of any comprehensive solution. Key supply-side measures include avoiding overprescribing, reducing diversion, and discouraging misuse through changes in drug formulations. Important demand-side measures center around educating patients and clinicians regarding the pitfalls of opioid overuse and methods to avoid unnecessary exposure to these drugs. Anesthesiologists, by virtue of their expertise in the use of these drugs and their position in guiding opioid use around the time of surgery, have important roles to play in reducing patient exposure to opioids and providing education about appropriate use. Aside from the many immediate steps that can be taken, clinical and basic research directed at understanding the interaction between pain and opioid misuse is critical to identifying the optimal use of these powerful pain relievers in clinical practice.
引用
收藏
页码:1667 / 1674
页数:8
相关论文
共 50 条
  • [21] America's Deadly Opioid Epidemic From Which Everyone But the Users Profits
    Schwartz, Stephan A.
    EXPLORE-THE JOURNAL OF SCIENCE AND HEALING, 2017, 13 (04) : 240 - 242
  • [22] Evaluating the impact of Affordable Care Act repeal on America's opioid epidemic
    Wen, Leana S.
    Behrle, Evan B.
    Tsai, Alexander C.
    PLOS MEDICINE, 2017, 14 (08)
  • [23] The opioid mortality epidemic in North America: do we understand the supply side dynamics of this unprecedented crisis?
    Fischer, Benedikt
    Pang, Michelle
    Jones, Wayne
    SUBSTANCE ABUSE TREATMENT PREVENTION AND POLICY, 2020, 15 (01)
  • [24] The opioid mortality epidemic in North America: do we understand the supply side dynamics of this unprecedented crisis?
    Benedikt Fischer
    Michelle Pang
    Wayne Jones
    Substance Abuse Treatment, Prevention, and Policy, 15
  • [25] Pharmacokinetic and pharmacodynamic considerations in developing a response to the opioid epidemic
    Balyan, Rajiv
    Hahn, David
    Huang, Henry
    Chidambaran, Vidya
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2020, 16 (02) : 125 - 141
  • [26] SUPPLY AND DEMAND CONSIDERATIONS OF AGRIBUSINESS MARKETING PORTFOLIOS
    BUCCOLA, ST
    AMERICAN JOURNAL OF AGRICULTURAL ECONOMICS, 1980, 62 (05) : 1113 - 1113
  • [27] Considerations in addressing the opioid epidemic and chronic pain within the USA
    Marshall, Blaine
    Bland, Michelle K.
    Hulla, Ryan
    Gatchel, Robert J.
    PAIN MANAGEMENT, 2019, 9 (02) : 131 - 138
  • [28] Supply and demand in the pediatric NP workforce: Who will care for America's children?
    Bowser, Jonathan
    Reed, Harrison
    Fraher, Erin
    JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2015, 28 (07): : 61 - 61
  • [29] Combatting the Obesity Epidemic in Rural America: A Few Considerations
    Meyer, M. Renee Umstattd
    JOURNAL OF PUBLIC HEALTH MANAGEMENT AND PRACTICE, 2013, 19 (06): : 501 - 502
  • [30] SUPPLY AND DEMAND FOR SWEETENERS IN LATIN-AMERICA
    AHLFELD, H
    SUGAR Y AZUCAR, 1982, 77 (04): : 11 - &